Mark Fyvie is a biopharma entrepreneur whose career began with a PhD from the University of Cambridge (UK). He has since built extensive experience across the biopharmaceutical industry, spanning research, drug development, and company building. He currently leads Vx Pharma, applying his scientific background and entrepreneurial acumen to assist clinical stage startups advance their therapeutic […]
Kevin Heath, MD, MPH, FACP is a board-certified internist and nephrologist who has spent his career inside one of the largest payer-provider enterprises in the country. He now leads Heath Clinical Intelligence Advisory, providing consulting expertise at the intersection of clinical medicine, population health, and integrated payer-provider strategy.nnHis expertise spans clinical operations, quality of care, […]
I am a medical oncologist and drug developer dedicated to translating innovative science into breakthrough therapies for patients with cancer. As Executive Chair of Head & Neck Research at Sarah Cannon Research Institute, I am recognized as a key opinion leader in head & neck oncology, shaping the design and execution of early clinical development […]
I am a physician (MBBS) with a Master of Science in Medical Biotechnology and more than eight years of experience leading clinical research, clinical operations, and healthcare innovation initiatives across academic, healthcare, and industry settings. My expertise spans Phase I–IV clinical trials, clinical development, regulatory strategy, translational medicine, medical affairs, due diligence, and program leadership. […]